IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB)

Historical Holders from Q2 2025 to Q3 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
INAB on Nasdaq
Shares outstanding
9,777,240
Price per share
$2.17
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
693,655
Total reported value
$1,505,233
% of total 13F portfolios
0%
Share change
+104,838
Value change
+$239,507
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
18
Price from insider filings
$1.38
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Stonepine Capital Management, LLC 9.9% $1,975,660 1,007,990 Stonepine Capital Management, LLC 19 Dec 2025
683 Capital Management, LLC 7.9% $1,510,072 770,445 683 Capital Management, LLC 22 Dec 2025
FAIRBAIRN EMILY 7.5% $1,268,597 733,293 EMILY FAIRBAIRN 22 Dec 2025
Ho William Tai-Wei 3.7% $349,325 151,223 William Tai-Wei Ho 30 Jun 2025
Transcend Partners Opportunity Fund I LLC 2.6% $248,131 107,416 Transcend Partners Opportunity Fund LLC 30 Jun 2025
As of 30 Sep 2025, IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB) has 18 institutional shareholders filing 13F forms. They hold 693,655 shares. of 9,777,240 outstanding shares (7.1%) .

Institutional Holders of IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 693,655 $1,505,233 +$239,507 217% 18
2025 Q2 588,817 $1,230,632 +$1,230,632 209% 11